4th Quarter - Amendment

AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 23, 2017 $40,000 Replaced
4th Quarter - Amendment (this page) Feb 22, 2017 $40,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR592/S314 Pharmacy and Medically Underserved Areas Enhancement Act,

LobbyistCovered position, as disclosed
PETER RANKIN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 592 (114th)

Health Issues HCR

Pharmacy Lock-in (s.1913, S.524), Pharmacy provider status (H.R. 592/S.314),

LobbyistCovered position, as disclosed
PETER RANKIN Director of Policy and Advocacy

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 524 (114th), S. 314 (114th), H.R. 592 (114th), S. 1913 (114th)

Pharmacy PHA

H.R. 592/S.314 Pharmacy and Medically Underserved Areas Enhancement Act, Impact Act Implementation, Repackaging and compounding guidance, controlled substances act requirements for electronic e-kits.

LobbyistCovered position, as disclosed
PETER RANKIN —

Contacted: SENATE; Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 314 (114th), H.R. 592 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.